PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-50.42%
Negative net income growth while MCHP stands at 24.56%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
46.90%
Some D&A expansion while MCHP is negative at -2.64%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1933.33%
Negative yoy deferred tax while MCHP stands at 62.09%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-29.03%
Both cut yoy SBC, with MCHP at -4.06%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
98.12%
Slight usage while MCHP is negative at -521.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
972.73%
AR growth while MCHP is negative at -39.58%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
822.73%
Inventory growth well above MCHP's 88.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-61.54%
Both reduce yoy usage, with MCHP at -250.95%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-3600.00%
Negative yoy while MCHP is 2191.32%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-14.67%
Negative yoy CFO while MCHP is 9.99%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
20.73%
CapEx growth well above MCHP's 28.78%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-53.61%
Both yoy lines negative, with MCHP at -115.58%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-76.77%
We reduce yoy sales while MCHP is 48.92%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Growth well above MCHP's 27.51%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
78.76%
We have mild expansions while MCHP is negative at -20.83%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
83.33%
Debt repayment growth of 83.33% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
284.85%
We slightly raise equity while MCHP is negative at -29.18%. John Neff sees competitor possibly preserving share count or buying back shares.
33.33%
Buyback growth of 33.33% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.